Literature DB >> 24064358

Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4.

Sandra Feijóo-Bandín1, Diego Rodríguez-Penas, Vanessa García-Rúa, Ana Mosquera-Leal, Manuel Francisco Otero, Eva Pereira, José Rubio, Isabel Martínez, Luisa María Seoane, Oreste Gualillo, Manuel Calaza, Tomás García-Caballero, Manuel Portolés, Esther Roselló-Lletí, Carlos Diéguez, Miguel Rivera, José Ramón González-Juanatey, Francisca Lago.   

Abstract

Nesfatin-1, a satiety-inducing peptide identified in hypothalamic regions that regulate energy balance, is an integral regulator of energy homeostasis and a putative glucose-dependent insulin coadjuvant. We investigated its production by human cardiomyocytes and its effects on glucose uptake, in the main cardiac glucose transporter GLUT-4 and in intracellular signaling. Quantitative RT-PCR, Western blots, confocal immunofluorescence microscopy, and ELISA of human and murine cardiomyocytes and/or cardiac tissue showed that cardiomyocytes can synthesize and secrete nesfatin-1. Confocal microscopy of cultured cardiomyocytes after GLUT-4 labeling showed that nesfatin-1 mobilizes this glucose transporter to cell peripherals. The rate of 2-deoxy-D-[(3)H]glucose incorporation demonstrated that nesfatin-1 induces glucose uptake by HL-1 cells and cultured cardiomyocytes. Nesfatin-1 induced dose- and time-dependent increases in the phosphorylation of ERK1/2, AKT, and AS160. In murine and human cardiac tissue, nesfatin-1 levels varied with diet and coronary health. In conclusion, human and murine cardiomyocytes can synthesize and secrete nesfatin-1, which is able to induce glucose uptake and the mobilization of the glucose transporter GLUT-4 in these cells. Nesfatin-1 cardiac levels are regulated by diet and coronary health.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24064358     DOI: 10.1210/en.2013-1497

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  24 h nesfatin-1 treatment promotes apoptosis in cardiomyocytes.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; Emad Abu-Assi; Manuel Portolés; Esther Roselló-Lletí; Miguel Rivera; Carlos Diéguez; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-06-05       Impact factor: 3.633

2.  Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.

Authors:  Figen Kir Sahin; Serap Baydur Sahin; Ulku Mete Ural; Medine Cumhur Cure; Senol Senturk; Yesim Bayoglu Tekin; Gulsah Balik; Erkan Cure; Suleyman Yuce; Aynur Kirbas
Journal:  Bosn J Basic Med Sci       Date:  2015-07-09       Impact factor: 3.363

3.  Expression and function of nesfatin-1 are altered by stage of the estrous cycle.

Authors:  Alicia T Pate; Abigayle L Schnell; Teresa A Ennis; Willis K Samson; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-29       Impact factor: 3.619

4.  Necroptosis and RhoA/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia/reperfusion injury in a rat model.

Authors:  Masoomeh Sharifi; Donya Nazarinia; Fatemeh Ramezani; Yaser Azizi; Nasim Naderi; Nahid Aboutaleb
Journal:  Mol Biol Rep       Date:  2021-03-23       Impact factor: 2.316

5.  Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level.

Authors:  Vanessa Garcia-Rua; Sandra Feijoo-Bandin; Maria Garcia-Vence; Alana Aragon-Herrera; Susana B Bravo; Diego Rodriguez-Penas; Ana Mosquera-Leal; Pamela V Lear; John Parrington; Jana Alonso; Esther Rosello-Lleti; Manuel Portoles; Miguel Rivera; Jose Ramon Gonzalez-Juanatey; Francisca Lago
Journal:  J Biosci       Date:  2016-12       Impact factor: 1.826

Review 6.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

7.  Dietary lipid content reorganizes gut microbiota and probiotic L. rhamnosus attenuates obesity and enhances catabolic hormonal milieu in zebrafish.

Authors:  Silvia Falcinelli; Ana Rodiles; Azadeh Hatef; Simona Picchietti; Lina Cossignani; Daniel L Merrifield; Suraj Unniappan; Oliana Carnevali
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

8.  Study of the effects of nesfatin-1 on gastric function in obese rats.

Authors:  Guo-Tao Yang; Hong-Ying Zhao; Yu Kong; Ning-Ning Sun; Ai-Qin Dong
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

9.  The effects of Desflurane and Sevoflurane on Nesfatin-1 levels in laparoscopic Cholecystectomy: a randomized controlled trial.

Authors:  A T D Ozcan; C B Altin; S Erdogan; M Ergin; A Çiftçi; H Kara; S M Aksoy; A But
Journal:  BMC Anesthesiol       Date:  2018-02-16       Impact factor: 2.217

10.  Catestatin Induces Glucose Uptake and GLUT4 Trafficking in Adult Rat Cardiomyocytes.

Authors:  Maria Pia Gallo; Saveria Femminò; Susanna Antoniotti; Giulia Querio; Giuseppe Alloatti; Renzo Levi
Journal:  Biomed Res Int       Date:  2018-10-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.